Searched for
ZENFLOX
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Usually, official talks are mere formalities – meetings to ink things that have already been agreed upon. The one scheduled between the US ...
- Time to increase the risk quotient? Maybe, but selectively: 5 large-caps from different sectors with upside potential of up to 28%With Israel refusing to play ball and Iran maintaining its vice-like hold on the Strait of Hormuz, the ceasefire declared by US President T...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%The market is again abuzz with the possibility of peace in the Gulf. This has, however, happened in the past. There is, thus, no point in g...
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...
- As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...
- Stay with select few with tailwinds of either restructuring or demand: 5 large-cap stocks from different sectors with an upside potential of 35%When it comes to large-caps, we think of Reliance, TCS, L&T or Infosys. The fact, however, is that these are not large-caps – they are mega...
- Corrections are opportunities, if you enter the right sector and stocks: 5 stocks from pharma sector with an upside potential of up to 32%At a time when the Nifty and Sensex are trading with cuts in excess of 1%, talking of buying stocks may not appear quite right. But correct...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Simple moat is good enough reason : 5 large cap stocks from different sector with right ratio matrix and upside potential of upto 38%There are many textbook definitions of the word “ moat”. But what it means in simple terms is that there has to be something in a business ...
- Volatility in market is different from volatile business: 5 large cap stocks with upside potential ranging from just 2% upto 46%There cannot be any doubt about volatility on the street, both as reflected by advance decline ratio or the kind of movement we see in nift...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- Mankind Pharma plans $1 billion IPO, hires bankersIn the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...
- Government ban on 350 drugs jolts 4% of pharma retail marketPfizer and Abbott and domestic companies including Alkem, Ipca and MacLeods, and is likely to be contested by companies, sources say.
- Cos changing diarrhoea syrup formula to evade price controlNext time your child refuses to take the diarohhea syrup, don’t blame the poor kid. The change in the chemical composition of popular paedi...
- Mankind Pharma in talks with PE funds to offload 5% stakeDelhi-based Mankind Pharma is holding parleys with some of the leading private equity funds for a private placement deal.
Load More
